JP2001519815A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001519815A5 JP2001519815A5 JP1998543154A JP54315498A JP2001519815A5 JP 2001519815 A5 JP2001519815 A5 JP 2001519815A5 JP 1998543154 A JP1998543154 A JP 1998543154A JP 54315498 A JP54315498 A JP 54315498A JP 2001519815 A5 JP2001519815 A5 JP 2001519815A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4189097P | 1997-04-10 | 1997-04-10 | |
| US60/041,890 | 1997-04-10 | ||
| PCT/US1998/007234 WO1998044940A1 (en) | 1997-04-10 | 1998-04-10 | Use of lactoferin in the treatment of allergen induced disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001519815A JP2001519815A (ja) | 2001-10-23 |
| JP2001519815A5 true JP2001519815A5 (https=) | 2005-11-24 |
Family
ID=21918897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54315498A Ceased JP2001519815A (ja) | 1997-04-10 | 1998-04-10 | アレルゲン誘発性障害の治療におけるラクトフェリンの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030190303A1 (https=) |
| EP (1) | EP0979099B1 (https=) |
| JP (1) | JP2001519815A (https=) |
| CN (1) | CN1262625A (https=) |
| AT (1) | ATE297755T1 (https=) |
| AU (1) | AU747385C (https=) |
| CA (1) | CA2285960A1 (https=) |
| DE (1) | DE69830582T2 (https=) |
| ES (1) | ES2245028T3 (https=) |
| IL (1) | IL132293A0 (https=) |
| NZ (1) | NZ500712A (https=) |
| WO (1) | WO1998044940A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0980261A4 (en) * | 1997-05-03 | 2003-04-23 | Univ Texas | METHOD FOR PREVENTING AND TREATING A METABOLIC INBALANCE Caused By Insulin In Humans And Other Animals |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| AU782539B2 (en) * | 2000-01-14 | 2005-08-04 | Meiji Dairies Corporation | Antigen-specific IgE antibody production inhibitors |
| RU2165769C1 (ru) * | 2000-07-13 | 2001-04-27 | Якубовская Раиса Ивановна | Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения |
| EP2295081B1 (en) | 2001-06-26 | 2018-10-31 | Amgen Inc. | Antibodies to OPGL |
| JP3668241B2 (ja) * | 2001-12-28 | 2005-07-06 | 株式会社Ｎｒｌファーマ | 脂質代謝改善用組成物 |
| WO2003061688A1 (en) * | 2002-01-21 | 2003-07-31 | Nrl Pharma, Inc. | Novel analgesics |
| AU2003239393A1 (en) | 2002-05-10 | 2003-11-11 | Agennix Incorporated | Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| AU2003233583A1 (en) | 2002-05-24 | 2003-12-12 | Agennix Incorporated | Oral lactoferrin in the treatment of respiratory disorders |
| KR101317045B1 (ko) | 2002-09-06 | 2013-10-16 | 암젠 인코포레이티드 | 치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체 |
| EP2298338B1 (en) * | 2002-09-16 | 2012-08-22 | Agennix Incorporated | Lactoferrin compositions and methods of treatment of skin wounds |
| WO2004052281A2 (en) * | 2002-12-06 | 2004-06-24 | Agennix Incorporated | Oral lactoferrin in the treatment of sepsis |
| WO2004052305A2 (en) | 2002-12-10 | 2004-06-24 | Agennix Incorporated | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| WO2005046571A2 (en) * | 2003-06-06 | 2005-05-26 | Agennix Incorporated | Lactoferrin as an adjuvant in cancer vaccines |
| US20050075277A1 (en) * | 2003-07-10 | 2005-04-07 | Agennix Incorporated | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
| WO2005121329A2 (en) * | 2004-06-11 | 2005-12-22 | Syngenta Limited | Method for ameliorating an inflammatory skin condition |
| WO2006047744A2 (en) | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions of lactoferrin related peptides and uses thereof |
| DK1833495T3 (da) * | 2005-03-15 | 2008-06-02 | Campina Nederland Holding Bv | Dermatologisk anvendelse af mælkeproteiner |
| US8178486B2 (en) * | 2005-07-21 | 2012-05-15 | Animal Technology Institute Taiwan | Method for promoting hair growth |
| EP1937298A4 (en) * | 2005-10-14 | 2009-11-11 | Auckland Uniservices Ltd | USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES |
| JPWO2007049757A1 (ja) * | 2005-10-27 | 2009-04-30 | サンスター株式会社 | ラクトフェリンを含んだリポソームを含有する破骨細胞増加抑制剤、経口組成物及び骨疾患の予防又は治療剤 |
| CN105412912A (zh) * | 2010-04-23 | 2016-03-23 | 普若拜特有限公司 | 湿疹治疗 |
| CN102370964B (zh) * | 2010-08-16 | 2015-12-09 | 李兴德 | 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用 |
| IT201800002457A1 (it) * | 2018-02-07 | 2019-08-07 | Neilos S R L | Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie |
| US12403181B2 (en) | 2018-08-13 | 2025-09-02 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
| CN114867368A (zh) * | 2019-12-11 | 2022-08-05 | N·V·努特里奇亚 | 用于提高免疫适宜的营养组合物 |
| WO2023222565A1 (en) | 2022-05-16 | 2023-11-23 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
| CN115737787B (zh) * | 2022-12-15 | 2024-04-19 | 四川大学 | 乳铁蛋白联合胆碱在制备预防和/或治疗阿尔兹海默症的药物中的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2596986B1 (fr) * | 1986-04-11 | 1988-09-23 | Sederma Sa | Utilisation de la lactoferrine dans des preparations cosmetiques, antiradicaux libres |
| FR2641696B2 (fr) * | 1986-04-11 | 1991-03-08 | Sederma Sa | Utilisation d'un melange renfermant de la lactoferrine dans des preparations cosmetiques anti-radicaux libres |
| FR2685202B1 (fr) * | 1991-12-24 | 1995-03-24 | Sederma Sa | Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee. |
| JP3184923B2 (ja) * | 1992-01-08 | 2001-07-09 | ビオ セレ ラボラトワール エス ア | 抗リウマチ剤 |
| JPH05279266A (ja) * | 1992-04-02 | 1993-10-26 | Imuno Japan:Kk | 歯周病の治療・予防用医薬組成物 |
| JP3163171B2 (ja) * | 1992-07-15 | 2001-05-08 | 森永乳業株式会社 | ＩｇＡ産生促進剤 |
| JP3746081B2 (ja) * | 1994-02-24 | 2006-02-15 | 森永乳業株式会社 | 動物皮膚病治療剤 |
| JPH0859450A (ja) * | 1994-08-18 | 1996-03-05 | Kose Corp | 皮膚外用剤 |
| JP2832517B2 (ja) * | 1994-12-09 | 1998-12-09 | 雪印乳業株式会社 | 大腸菌付着阻止剤 |
| JP3911642B2 (ja) * | 1995-06-06 | 2007-05-09 | 株式会社加美乃素本舗 | 皮膚外用剤 |
| JP3888707B2 (ja) * | 1996-01-22 | 2007-03-07 | 森永乳業株式会社 | 血管新生病治療剤 |
| US6111081A (en) * | 1996-05-31 | 2000-08-29 | Baylor College Of Medicine | Lactoferrin variants and uses thereof |
-
1998
- 1998-04-10 EP EP98915471A patent/EP0979099B1/en not_active Expired - Lifetime
- 1998-04-10 AU AU69647/98A patent/AU747385C/en not_active Ceased
- 1998-04-10 CA CA002285960A patent/CA2285960A1/en not_active Abandoned
- 1998-04-10 US US09/058,589 patent/US20030190303A1/en not_active Abandoned
- 1998-04-10 AT AT98915471T patent/ATE297755T1/de not_active IP Right Cessation
- 1998-04-10 ES ES98915471T patent/ES2245028T3/es not_active Expired - Lifetime
- 1998-04-10 NZ NZ500712A patent/NZ500712A/xx not_active IP Right Cessation
- 1998-04-10 JP JP54315498A patent/JP2001519815A/ja not_active Ceased
- 1998-04-10 IL IL13229398A patent/IL132293A0/xx not_active IP Right Cessation
- 1998-04-10 CN CN98805584A patent/CN1262625A/zh active Pending
- 1998-04-10 WO PCT/US1998/007234 patent/WO1998044940A1/en not_active Ceased
- 1998-04-10 DE DE69830582T patent/DE69830582T2/de not_active Expired - Lifetime